-
Security Type
-
SAFE
-
Expected Close Date
-
August 21, 2023
-
Target Raise
-
$10.00K-$5.00M
-
Security Price
-
$0.25
- Number of Employees
- 245
- Cash
- $4,176,049
- Revenue
- $18,588,589
- Short Term Debt
- $0
- Cost of Goods
- $13,001,365
- Long Term Debt
- $0
- Net Income
- $5,307,372
Company Description
Yasheng Group is a U.S. company, that conducts business operations in the US, China, and the Philippines in four major segments: Agriculture & Fisheries, Biotechnology, Blockchain, and Mining. Yasheng Group plans to raise this round for the Biotechnology segment of their company, and more specifically, for Jove Therapeutics. Jove Therapeutic’s mission is to expand tomorrow’s cutting-edge technology for the development of multiple myeloma and other cancer treatment.
Management Team / Advisory Board Bios
Anxue Wang
Director
BackgroundAnxue Wang served as a Senior Engineer with the Suzhou Municipal Water Affairs Bureau in China from2000 to 2010, in charge of water resources engineering survey and design. During that period, he won a Second Prize in Science and Technology Progress at the Gansu Province level. Mr. Wang currently is an independent director. He also serves as both a member of the Compensation Committee and a member of the Audit Committee.